Tradestie Institutional Equity Comparison Engine

AMBQ vs MCHPP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMBQ Overall Edge

AMBQ Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ambiq Micro, Inc. (AMBQ) driven by superior Momentum & Technical, Options & Structure while MCHPP counters with relative strength in Growth & Margin. Fundamentally, AMBQ trades at N/M Forward P/E with -36.0% operating margin (+110.0% YoY revenue) versus MCHPP at N/M Forward P/E and 21.6% operating margin (+42.2% YoY). In options structure, AMBQ sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro) against MCHPP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AMBQ N/M vs MCHPP N/M Fwd P/E
Growth & Margin Winner MCHPP
Op Margin -36.0% vs 21.6% ยท YoY +110.0% vs +42.2%
Momentum & Technical Winner AMBQ
1Y +72.4% vs +0.8% ยท 52W Pos 32% vs 14%
Options & Structure Winner AMBQ
BREAKDOWN (27th %ile IV) vs UNCLASSIFIED (N/A IV)
AMBQ NYSE
Ambiq Micro, Inc.
Semiconductors & Related Devices
$44.59
-6.05% 1D
Market Cap $1.2B
1M Return -10.61%
1Y Return +72.36%
Forward P/E N/M
Unified AI Score
46.9 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 65.0 Mom 50.0
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
1M Return -17.41%
1Y Return +0.8%
Forward P/E N/M
Unified AI Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AMBQ +72.36% MCHPP +0.8% Spread: +71.56 pp (AMBQ Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AMBQ TTM Op. Margin: -36.0% MCHPP TTM Op. Margin: 21.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMBQ vs MCHPP. Trailing 12-month operating profitability (AMBQ -36.0% vs MCHPP 21.6%) and valuation multiples (AMBQ N/M vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AMBQ (3) vs MCHPP (5)
Institutional Metric AMBQ MCHPP Criterion Row Winner
Market Capitalization Scale $1.2B N/A Larger Scale AMBQ
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +110.0% +42.2% Higher Growth AMBQ
Operating Margin (TTM) Profitability -36.0% 21.6% Higher Margin MCHPP
Net Profit Margin Profitability -29.7% 15.0% Higher Margin MCHPP
Return on Equity (ROE) Capital Efficiency -12.2% 12.6% Higher ROE MCHPP
52-Week Range Position Momentum 32% ($22โ€“$92) 14% ($47โ€“$88) Stronger Trend AMBQ
Beta / 30D Volatility Risk Regime 3.71ฮฒ ยท 125% Vol 2.16ฮฒ ยท 65% Vol Lower Realized Risk MCHPP
Unified Institutional Score Composite Signal 46.9 / 100 (HOLD) 57.1 / 100 (HOLD) Higher Composite MCHPP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AMBQ vs MCHPP Buy Guide
AMBQ BREAKDOWN
104d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 27th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AMBQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MCHPP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MCHPP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AMBQ nor MCHPP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.